Learn More
Effects of can-desartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. of all-cause heart failure and borderline left ventricular systolic dysfunction: 5-year mortality follow-up of the Echocardiographic A 48-year-old woman presented worsening of dyspnoea in the previous 6 months.(More)
OBJECTIVE The toxicity of anti-cancer chemotherapeutic agents can be reduced by associating these compounds, such as the anti-proliferative agent paclitaxel, with a cholesterol-rich nanoemulsion (LDE) that mimics the lipid composition of low-density lipoprotein (LDL). When injected into circulation, the LDE concentrates the carried drugs in neoplastic(More)
  • 1